Back

Total hospitalizations after peripheral arterial revascularization in the VOYAGER trial

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Peripheral arterial and cerebrovascular disease 1 Peripheral Artery Disease ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Michael Szarek

University of Colorado School of Medicine, Aurora (United States of America)

5 More presentations in this session

Presentation thumbnail
The impact of statin treatment intensity after endovascular revascularization for lower extremity peripheral artery disease
Doctor J. Seo (Seoul, KR)
Abstract Slides
Presentation thumbnail
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation: observations from the GARFIELD-AF registry
Ms M. Pope (Oslo, NO)
Abstract Slides
Presentation thumbnail
The interaction effect of CHA2DS2-VASc components on ischemic stroke risk after atrial fibrillation: a population-based cohort study
Mr K. Bonnesen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Left ventricular longitudinal contraction impacts the left atrial appendage function and the occurrence of thromboembolic events in patients with atrial fibrillation
Doctor A. Sarb (Cluj Napoca, RO)
Abstract Slides
Presentation thumbnail
Roadsaver versus Wallstent for carotid artery stenting: a retrospective cohort study
Assistant Professor Z. Ruzsa (Szeged, HU)
Abstract Slides

Access the full session

Session thumbnail
Peripheral arterial and cerebrovascular disease 1

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources